17beta-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats. 2007

K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
Laboratory of Neuropsychopharmacology, Graduate School of Natural Science and Technology, Kanazawa University, Kakuma-machi, Kanazawa 920-1192, Japan.

Several lines of evidence suggest that hormonal changes after menopause may play an important role in the incidence of cognitive dysfunction, and also in the development of Alzheimer's disease. In this study, we investigated the effect of estrogen on cognitive function in rats under different stress environment. Female rats were divided into four groups: two groups were ovariectomized (OVX) and two were sham-operated. One group each of OVX and sham rats was kept in a normal environment, and the other groups were assigned to a daily restraint stress (6 h/day) for 21 days from 2 months after the operation. Following the stress period, subjects were tested for performance in novel object recognition test and then used for morphological and neurochemical analyses. The OVX plus stress (OVX/stress) group showed a significant impairment of recognition of novel objects, compared with the other groups. The OVX/stress group also showed a marked decrease in the number of pyramidal cells of the CA3 region and levels of brain-derived neurotrophic factor mRNA in the hippocampus. We further examined the effect of estrogen against cognitive dysfunction and hippocampal changes of OVX/stress rats. Vehicle or 17beta-estradiol (E2) at 20 microg/day was s.c. administered to OVX/stress rats from 2 days before the stress period to the end of behavioral analysis through an implantable osmotic pump. Chronic E2 treatment decreased stress response and improved the cognitive and morphological impairments relative to vehicle group. These data have important implications for cognition enhancing effect of estrogen treatment in postmenopausal women.

UI MeSH Term Description Entries
D009474 Neurons The basic cellular units of nervous tissue. Each neuron consists of a body, an axon, and dendrites. Their purpose is to receive, conduct, and transmit impulses in the NERVOUS SYSTEM. Nerve Cells,Cell, Nerve,Cells, Nerve,Nerve Cell,Neuron
D010052 Ovariectomy The surgical removal of one or both ovaries. Castration, Female,Oophorectomy,Bilateral Ovariectomy,Bilateral Ovariectomies,Castrations, Female,Female Castration,Female Castrations,Oophorectomies,Ovariectomies,Ovariectomies, Bilateral,Ovariectomy, Bilateral
D011916 Rats, Inbred F344 An inbred strain of rat that is used for general BIOMEDICAL RESEARCH purposes. Fischer Rats,Rats, Inbred CDF,Rats, Inbred Fischer 344,Rats, F344,Rats, Inbred Fisher 344,CDF Rat, Inbred,CDF Rats, Inbred,F344 Rat,F344 Rat, Inbred,F344 Rats,F344 Rats, Inbred,Inbred CDF Rat,Inbred CDF Rats,Inbred F344 Rat,Inbred F344 Rats,Rat, F344,Rat, Inbred CDF,Rat, Inbred F344,Rats, Fischer
D012149 Restraint, Physical Use of a device for the purpose of controlling movement of all or part of the body. Splinting and casting are FRACTURE FIXATION. Immobilization, Physical,Physical Restraint,Physical Immobilization,Physical Restraints,Restraints, Physical
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D003072 Cognition Disorders Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment. Overinclusion,Disorder, Cognition,Disorders, Cognition
D003345 Corticosterone An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437)
D004958 Estradiol The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. 17 beta-Estradiol,Estradiol-17 beta,Oestradiol,17 beta-Oestradiol,Aerodiol,Delestrogen,Estrace,Estraderm TTS,Estradiol Anhydrous,Estradiol Hemihydrate,Estradiol Hemihydrate, (17 alpha)-Isomer,Estradiol Monohydrate,Estradiol Valerate,Estradiol Valeriante,Estradiol, (+-)-Isomer,Estradiol, (-)-Isomer,Estradiol, (16 alpha,17 alpha)-Isomer,Estradiol, (16 alpha,17 beta)-Isomer,Estradiol, (17-alpha)-Isomer,Estradiol, (8 alpha,17 beta)-(+-)-Isomer,Estradiol, (8 alpha,17 beta)-Isomer,Estradiol, (9 beta,17 alpha)-Isomer,Estradiol, (9 beta,17 beta)-Isomer,Estradiol, Monosodium Salt,Estradiol, Sodium Salt,Estradiol-17 alpha,Estradiol-17beta,Ovocyclin,Progynon-Depot,Progynova,Vivelle,17 beta Estradiol,17 beta Oestradiol,Estradiol 17 alpha,Estradiol 17 beta,Estradiol 17beta,Progynon Depot
D005260 Female Females
D005786 Gene Expression Regulation Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control (induction or repression) of gene action at the level of transcription or translation. Gene Action Regulation,Regulation of Gene Expression,Expression Regulation, Gene,Regulation, Gene Action,Regulation, Gene Expression

Related Publications

K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
September 2021, Hormones and behavior,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
May 2016, Biomolecules & therapeutics,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
July 2015, Behavioural brain research,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
January 2012, Journal of pharmacological sciences,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
July 2012, Behavioural brain research,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
November 2000, American journal of physiology. Regulatory, integrative and comparative physiology,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
January 2015, International journal of clinical and experimental pathology,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
June 2010, Hippocampus,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
May 2021, Brain and behavior,
K Takuma, and A Matsuo, and Y Himeno, and Y Hoshina, and Y Ohno, and Y Funatsu, and S Arai, and H Kamei, and H Mizoguchi, and T Nagai, and K Koike, and M Inoue, and K Yamada
December 2000, Endocrinology,
Copied contents to your clipboard!